Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Daxor continues development of BVA-100:

This article was originally published in Clinica

Executive Summary

Daxor (US) is to continue development of its BVA-100 blood volume analyser now that production of its albumin I-131 isotope has been approved by the US FDA. A suspended 510(k) application for the BVA-100 will now continue after eight years waiting for approval of the isotope. Iodine-131 is essential for measuring blood volume and will be part of the test kit for the New York-based company's analyser used during surgery. The albumin I-131 will be manufactured by Texas-based Iso-Tex Diagnostics.

Topics

UsernamePublicRestriction

Register

MT088142

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel